Not a single rupee will be lost to Chinese firms who provided faulty COVID-19 test kits to India as the orders have been cancelled and the payments not made, the government said on Monday amid a controversy over the issue.
Coronavirus test kits made by two Chinese companies Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics have been found “under-performing” by the Indian Council of Medical Research (ICMR), the government said.
It has asked states and hospitals to stop using the kits made by the two companies and since “due process followed (not going for procurement with 100% advance amount), GoI (Government of India) does not stand to lose a single rupee”, an official statement said.
#PIBFactCheck #IndiaFightsCorona : here are the actual facts on the controversy around prices of Rapid Antibody tests
for #Covid_19 https://t.co/z8Npr6l3ma— PIB India #StayHome #StaySafe (@PIB_India) April 27, 2020
Notably, ICMR has already asked states to return the faulty test kits.
COVID-19: Ahmedabad reports 18 deaths, 178 cases in 24-hours; Gujarat’s case count at 3,301
